| Product Code: ETC12736366 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Taiwan Nervous System Therapeutics Market Overview |
3.1 Taiwan Country Macro Economic Indicators |
3.2 Taiwan Nervous System Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Taiwan Nervous System Therapeutics Market - Industry Life Cycle |
3.4 Taiwan Nervous System Therapeutics Market - Porter's Five Forces |
3.5 Taiwan Nervous System Therapeutics Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 Taiwan Nervous System Therapeutics Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Taiwan Nervous System Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Taiwan Nervous System Therapeutics Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Taiwan Nervous System Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in Taiwan |
4.2.2 Growing awareness and focus on mental health and neurological well-being |
4.2.3 Technological advancements in nervous system therapeutics |
4.2.4 Rising healthcare expenditure and government initiatives to improve neurological care |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approvals in Taiwan |
4.3.2 Limited access to advanced neurological treatments in remote areas |
4.3.3 High cost of nervous system therapeutics and treatment |
4.3.4 Lack of skilled healthcare professionals specializing in neurological care |
5 Taiwan Nervous System Therapeutics Market Trends |
6 Taiwan Nervous System Therapeutics Market, By Types |
6.1 Taiwan Nervous System Therapeutics Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 Taiwan Nervous System Therapeutics Market Revenues & Volume, By Treatment Type, 2021 - 2031F |
6.1.3 Taiwan Nervous System Therapeutics Market Revenues & Volume, By Surgery, 2021 - 2031F |
6.1.4 Taiwan Nervous System Therapeutics Market Revenues & Volume, By Radiation Therapy, 2021 - 2031F |
6.1.5 Taiwan Nervous System Therapeutics Market Revenues & Volume, By Chemotherapy, 2021 - 2031F |
6.1.6 Taiwan Nervous System Therapeutics Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
6.2 Taiwan Nervous System Therapeutics Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Taiwan Nervous System Therapeutics Market Revenues & Volume, By Antidepressants, 2021 - 2031F |
6.2.3 Taiwan Nervous System Therapeutics Market Revenues & Volume, By Antipsychotics, 2021 - 2031F |
6.2.4 Taiwan Nervous System Therapeutics Market Revenues & Volume, By CNS Stimulants, 2021 - 2031F |
6.2.5 Taiwan Nervous System Therapeutics Market Revenues & Volume, By Mood Stabilizers, 2021 - 2031F |
6.3 Taiwan Nervous System Therapeutics Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Taiwan Nervous System Therapeutics Market Revenues & Volume, By Alzheimer's Disease, 2021 - 2031F |
6.3.3 Taiwan Nervous System Therapeutics Market Revenues & Volume, By Parkinson's Disease, 2021 - 2031F |
6.3.4 Taiwan Nervous System Therapeutics Market Revenues & Volume, By Multiple Sclerosis, 2021 - 2031F |
6.3.5 Taiwan Nervous System Therapeutics Market Revenues & Volume, By Epilepsy, 2021 - 2031F |
6.4 Taiwan Nervous System Therapeutics Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Taiwan Nervous System Therapeutics Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Taiwan Nervous System Therapeutics Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.4.4 Taiwan Nervous System Therapeutics Market Revenues & Volume, By Ambulatory Surgical Centers, 2021 - 2031F |
6.4.5 Taiwan Nervous System Therapeutics Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
7 Taiwan Nervous System Therapeutics Market Import-Export Trade Statistics |
7.1 Taiwan Nervous System Therapeutics Market Export to Major Countries |
7.2 Taiwan Nervous System Therapeutics Market Imports from Major Countries |
8 Taiwan Nervous System Therapeutics Market Key Performance Indicators |
8.1 Patient satisfaction scores with nervous system therapeutics |
8.2 Number of clinical trials and research studies conducted in Taiwan for neurological disorders |
8.3 Adoption rate of innovative treatment modalities in the nervous system therapeutics market |
8.4 Percentage increase in funding for neurological research and development |
8.5 Rate of successful patient outcomes and recovery from neurological conditions |
9 Taiwan Nervous System Therapeutics Market - Opportunity Assessment |
9.1 Taiwan Nervous System Therapeutics Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 Taiwan Nervous System Therapeutics Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Taiwan Nervous System Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Taiwan Nervous System Therapeutics Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Taiwan Nervous System Therapeutics Market - Competitive Landscape |
10.1 Taiwan Nervous System Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Taiwan Nervous System Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here